Loading...
Market
Country with Highest Mpox Cases in Africa by End of 2024?
2
World Health Organization•WHO•Emergency Use Listing•Alinity•Abbott Molecular•Africa•Democratic Republic of Congo•DRC
Resolution / Starting Odds
Democratic Republic of Congo • 25%
Nigeria • 25%
Ghana • 25%
Other • 25%
WHO reports or official health ministry announcements from African countries.
Story
WHO Approves Abbott's Alinity m Mpox Test for Emergency Use Amid Rising African Outbreaks
Oct 3, 2024, 10:03 PM
The World Health Organization (WHO) has approved the first mpox (formerly known as monkeypox) diagnostic test for emergency use under its Emergency Use Listing (EUL) procedure. The test, called the Alinity m MPXV assay, is manufactured by Abbott Molecular. This approval aims to boost global access to mpox testing, particularly in the face of rising outbreaks in Africa, including concerns over an expanding outbreak in the Democratic Republic of Congo (DRC). The WHO's decision is a crucial step in enhancing global health responses to the disease and preventing an mpox pandemic.
View original story
Similar markets
Burundi • 25%
Democratic Republic of Congo • 25%
Nigeria • 25%
Other • 25%
Nigeria • 25%
Democratic Republic of the Congo • 25%
South Africa • 25%
Other • 25%
Nigeria • 25%
Democratic Republic of Congo • 25%
South Africa • 25%
Uganda • 25%
Democratic Republic of the Congo • 25%
Nigeria • 25%
South Africa • 25%
Democratic Republic of Congo • 25%
Burundi • 25%
Uganda • 25%
Other • 25%
Democratic Republic of the Congo • 25%
Kenya • 25%
Rwanda • 25%
Uganda • 25%
Democratic Republic of Congo • 25%
Nigeria • 25%
South Africa • 25%
Other • 25%
Burundi • 25%
DRC • 25%
Nigeria • 25%
Other • 25%
Democratic Republic of Congo • 25%
Nigeria • 25%
Kenya • 25%
Other • 25%
Zambia • 25%
Uganda • 25%
Democratic Republic of Congo • 25%
Other • 25%
Democratic Republic of Congo • 25%
Nigeria • 25%
Uganda • 25%
Other • 25%
Sweden • 25%
India • 25%
Bangladesh • 25%
Other • 25%
Democratic Republic of the Congo • 25%
Nigeria • 25%
Ghana • 25%
Other • 25%